02410 TYK MEDICINES-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.97X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 1.4% | Net Margin | N/A |
| Total Debt/Equity | 37.7% | Return on Equity | N/A |
| Price/Book | 11.22X | Return on Assets | N/A |
| (HKD 15.090) | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | -411.53 | -421.51 | -348.69 |
|---|---|---|---|
| Net Profit Growth (%) | +2.4 | -20.9 | N/A |
| Earnings Per Share (HKD) | -1.219 | -1.46 | -1.255 |
| Earnings Per Share Growth (%) | +16.5 | -16.3 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A |
| Book NAV (HKD) | 1.345 | N/A | N/A |
| Auditors' Opinion | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Operating Result | -114.064 | -219.533 | -48.0 | -173.849 |
| Profit Before Taxation | -114.065 | -219.533 | -48.0 | -173.849 |
| Profit /( Loss) After Taxation | -114.065 | -219.533 | -48.0 | -173.849 |
| Minority Interests | -1.888 | -0.48 | +293.3 | -0.31 |
| Net Profit | -112.177 | -219.053 | -48.8 | -173.539 |
| Earnings Per Share () | -0.3314 | -0.7349 | -54.9 | -0.6503 |
| Announcement Date | 2025-08-31 | 2024-08-30 | NA | 2024-08-30 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
